This pipeline computes the correlation between significant arm-level copy number variations (cnvs) and selected clinical features.
Testing the association between copy number variation 81 arm-level events and 8 clinical features across 512 patients, 155 significant findings detected with Q value < 0.25.
-
1p gain cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', and 'HISTOLOGICAL_TYPE'.
-
1q gain cnv correlated to 'YEARS_TO_BIRTH'.
-
3p gain cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.
-
3q gain cnv correlated to 'Time to Death' and 'YEARS_TO_BIRTH'.
-
4p gain cnv correlated to 'HISTOLOGICAL_TYPE'.
-
5p gain cnv correlated to 'Time to Death' and 'YEARS_TO_BIRTH'.
-
5q gain cnv correlated to 'Time to Death' and 'RACE'.
-
7p gain cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', 'KARNOFSKY_PERFORMANCE_SCORE', and 'RACE'.
-
7q gain cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
8q gain cnv correlated to 'RADIATION_THERAPY'.
-
9p gain cnv correlated to 'GENDER' and 'RADIATION_THERAPY'.
-
9q gain cnv correlated to 'GENDER', 'RADIATION_THERAPY', and 'HISTOLOGICAL_TYPE'.
-
10p gain cnv correlated to 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', and 'HISTOLOGICAL_TYPE'.
-
10q gain cnv correlated to 'HISTOLOGICAL_TYPE'.
-
11p gain cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.
-
12p gain cnv correlated to 'RADIATION_THERAPY'.
-
12q gain cnv correlated to 'Time to Death'.
-
13q gain cnv correlated to 'RADIATION_THERAPY'.
-
15q gain cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'KARNOFSKY_PERFORMANCE_SCORE'.
-
16q gain cnv correlated to 'HISTOLOGICAL_TYPE'.
-
17p gain cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
-
17q gain cnv correlated to 'Time to Death'.
-
18p gain cnv correlated to 'Time to Death'.
-
18q gain cnv correlated to 'Time to Death'.
-
19p gain cnv correlated to 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', and 'HISTOLOGICAL_TYPE'.
-
19q gain cnv correlated to 'Time to Death' and 'YEARS_TO_BIRTH'.
-
20p gain cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', and 'KARNOFSKY_PERFORMANCE_SCORE'.
-
20q gain cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', and 'KARNOFSKY_PERFORMANCE_SCORE'.
-
21q gain cnv correlated to 'YEARS_TO_BIRTH'.
-
22q gain cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.
-
xp gain cnv correlated to 'HISTOLOGICAL_TYPE'.
-
xq gain cnv correlated to 'YEARS_TO_BIRTH', 'GENDER', 'HISTOLOGICAL_TYPE', and 'ETHNICITY'.
-
1p loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', and 'HISTOLOGICAL_TYPE'.
-
1q loss cnv correlated to 'HISTOLOGICAL_TYPE'.
-
2p loss cnv correlated to 'RADIATION_THERAPY'.
-
2q loss cnv correlated to 'HISTOLOGICAL_TYPE'.
-
3p loss cnv correlated to 'Time to Death' and 'KARNOFSKY_PERFORMANCE_SCORE'.
-
3q loss cnv correlated to 'Time to Death'.
-
4p loss cnv correlated to 'YEARS_TO_BIRTH', 'GENDER', and 'HISTOLOGICAL_TYPE'.
-
4q loss cnv correlated to 'HISTOLOGICAL_TYPE'.
-
5p loss cnv correlated to 'RADIATION_THERAPY' and 'HISTOLOGICAL_TYPE'.
-
5q loss cnv correlated to 'RADIATION_THERAPY' and 'HISTOLOGICAL_TYPE'.
-
6p loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'RADIATION_THERAPY'.
-
6q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
8p loss cnv correlated to 'Time to Death'.
-
8q loss cnv correlated to 'Time to Death'.
-
9p loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', 'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.
-
9q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', and 'KARNOFSKY_PERFORMANCE_SCORE'.
-
10p loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
10q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
11p loss cnv correlated to 'Time to Death', 'RADIATION_THERAPY', and 'HISTOLOGICAL_TYPE'.
-
11q loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.
-
12q loss cnv correlated to 'HISTOLOGICAL_TYPE'.
-
13q loss cnv correlated to 'RADIATION_THERAPY'.
-
14q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'KARNOFSKY_PERFORMANCE_SCORE'.
-
16p loss cnv correlated to 'Time to Death' and 'YEARS_TO_BIRTH'.
-
16q loss cnv correlated to 'YEARS_TO_BIRTH' and 'RADIATION_THERAPY'.
-
17p loss cnv correlated to 'Time to Death', 'KARNOFSKY_PERFORMANCE_SCORE', and 'ETHNICITY'.
-
18p loss cnv correlated to 'YEARS_TO_BIRTH'.
-
18q loss cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.
-
19p loss cnv correlated to 'RACE' and 'ETHNICITY'.
-
19q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', and 'HISTOLOGICAL_TYPE'.
-
20p loss cnv correlated to 'RADIATION_THERAPY'.
-
21q loss cnv correlated to 'KARNOFSKY_PERFORMANCE_SCORE' and 'HISTOLOGICAL_TYPE'.
-
22q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', and 'KARNOFSKY_PERFORMANCE_SCORE'.
-
xq loss cnv correlated to 'Time to Death'.
Clinical Features |
Time to Death |
YEARS TO BIRTH |
GENDER |
RADIATION THERAPY |
KARNOFSKY PERFORMANCE SCORE |
HISTOLOGICAL TYPE |
RACE | ETHNICITY | ||
nCNV (%) | nWild-Type | logrank test | Wilcoxon-test | Fisher's exact test | Fisher's exact test | Wilcoxon-test | Fisher's exact test | Fisher's exact test | Fisher's exact test | |
7q gain | 151 (29%) | 361 |
1.69e-07 (7.31e-06) |
3.28e-10 (2.65e-08) |
0.495 (0.821) |
0.000867 (0.012) |
0.00641 (0.0526) |
0.0391 (0.195) |
0.00963 (0.0717) |
0.556 (0.859) |
6q loss | 62 (12%) | 450 |
1.96e-05 (0.000489) |
0.0291 (0.161) |
0.414 (0.747) |
0.0256 (0.147) |
0.000617 (0.00952) |
0.00136 (0.0173) |
0.0512 (0.225) |
0.563 (0.863) |
10p loss | 83 (16%) | 429 |
0 (0) |
5.96e-20 (1.29e-17) |
0.81 (0.984) |
0.000138 (0.00271) |
0.000218 (0.00392) |
9e-05 (0.00189) |
0.00884 (0.0666) |
0.804 (0.983) |
10q loss | 96 (19%) | 416 |
0 (0) |
2.03e-17 (3.29e-15) |
0.649 (0.905) |
4.74e-06 (0.000154) |
0.000462 (0.00749) |
4e-05 (0.00096) |
0.0252 (0.147) |
0.484 (0.82) |
7p gain | 121 (24%) | 391 |
6.05e-09 (4.35e-07) |
2.93e-10 (2.65e-08) |
0.21 (0.514) |
0.000824 (0.0116) |
0.00106 (0.0138) |
0.204 (0.506) |
0.0167 (0.109) |
1 (1.00) |
9p loss | 117 (23%) | 395 |
3.1e-06 (0.000112) |
0.00204 (0.0232) |
1 (1.00) |
0.000963 (0.013) |
0.0022 (0.0246) |
0.0582 (0.246) |
0.607 (0.894) |
0.669 (0.905) |
1p gain | 13 (3%) | 499 |
0.00396 (0.0401) |
0.0126 (0.0884) |
0.263 (0.575) |
0.0341 (0.179) |
0.811 (0.984) |
0.0083 (0.0648) |
0.555 (0.859) |
1 (1.00) |
20p gain | 43 (8%) | 469 |
8.27e-12 (8.93e-10) |
2.19e-08 (1.42e-06) |
0.873 (1.00) |
0.0401 (0.199) |
0.0124 (0.0882) |
0.199 (0.499) |
0.388 (0.721) |
0.503 (0.826) |
20q gain | 43 (8%) | 469 |
1.17e-12 (1.52e-10) |
2.98e-08 (1.75e-06) |
0.423 (0.757) |
0.0405 (0.199) |
0.0124 (0.0882) |
0.304 (0.626) |
0.626 (0.899) |
0.503 (0.826) |
xq gain | 39 (8%) | 473 |
0.32 (0.636) |
0.0496 (0.225) |
0.0043 (0.0416) |
0.294 (0.616) |
0.515 (0.832) |
0.00743 (0.0587) |
0.593 (0.884) |
0.0194 (0.123) |
1p loss | 184 (36%) | 328 |
9.05e-05 (0.00189) |
0.00101 (0.0134) |
0.853 (1.00) |
5.62e-08 (3.03e-06) |
0.269 (0.58) |
1e-05 (0.00027) |
0.317 (0.636) |
0.704 (0.922) |
9q loss | 50 (10%) | 462 |
0.00858 (0.0654) |
0.00595 (0.0516) |
1 (1.00) |
0.011 (0.0803) |
0.000384 (0.00638) |
0.879 (1.00) |
0.135 (0.401) |
1 (1.00) |
19q loss | 209 (41%) | 303 |
0.00139 (0.0173) |
0.0437 (0.21) |
0.928 (1.00) |
4.1e-06 (0.00014) |
0.322 (0.637) |
1e-05 (0.00027) |
0.917 (1.00) |
0.0929 (0.322) |
22q loss | 57 (11%) | 455 |
8.53e-08 (4.25e-06) |
2.06e-06 (8.32e-05) |
0.482 (0.82) |
0.035 (0.179) |
0.00527 (0.0481) |
0.12 (0.367) |
0.175 (0.453) |
0.56 (0.863) |
9q gain | 24 (5%) | 488 |
0.175 (0.453) |
0.0775 (0.292) |
0.00268 (0.0294) |
0.00173 (0.0212) |
0.567 (0.865) |
0.0586 (0.246) |
0.213 (0.516) |
0.661 (0.905) |
10p gain | 57 (11%) | 455 |
0.677 (0.905) |
0.0215 (0.134) |
0.258 (0.574) |
0.011 (0.0803) |
0.207 (0.509) |
0.00017 (0.00324) |
1 (1.00) |
0.136 (0.402) |
15q gain | 11 (2%) | 501 |
0.0508 (0.225) |
0.0259 (0.147) |
1 (1.00) |
0.542 (0.851) |
0.0138 (0.0929) |
0.404 (0.74) |
0.495 (0.821) |
1 (1.00) |
17p gain | 20 (4%) | 492 |
0.00555 (0.0499) |
0.0176 (0.114) |
0.106 (0.346) |
0.489 (0.821) |
0.666 (0.905) |
0.0595 (0.249) |
0.221 (0.532) |
1 (1.00) |
19p gain | 100 (20%) | 412 |
0.702 (0.921) |
0.013 (0.0906) |
0.22 (0.532) |
0.0581 (0.246) |
0.483 (0.82) |
1e-05 (0.00027) |
0.532 (0.843) |
0.111 (0.356) |
4p loss | 71 (14%) | 441 |
0.642 (0.905) |
0.00404 (0.0403) |
0.0542 (0.236) |
1 (1.00) |
0.958 (1.00) |
0.0003 (0.00512) |
0.511 (0.832) |
0.796 (0.982) |
6p loss | 30 (6%) | 482 |
8.3e-05 (0.00185) |
0.0548 (0.237) |
0.573 (0.865) |
0.0578 (0.246) |
0.0764 (0.29) |
0.231 (0.546) |
0.0626 (0.258) |
1 (1.00) |
11p loss | 63 (12%) | 449 |
0.0222 (0.137) |
0.265 (0.575) |
0.343 (0.662) |
0.00625 (0.0526) |
0.177 (0.454) |
0.00065 (0.0098) |
0.561 (0.863) |
0.784 (0.975) |
14q loss | 80 (16%) | 432 |
2.75e-06 (0.000105) |
1.66e-05 (0.000431) |
0.903 (1.00) |
0.156 (0.437) |
0.0339 (0.179) |
0.258 (0.574) |
0.228 (0.543) |
0.603 (0.892) |
17p loss | 13 (3%) | 499 |
0.0351 (0.179) |
0.0739 (0.285) |
0.263 (0.575) |
1 (1.00) |
0.00849 (0.0654) |
0.726 (0.941) |
1 (1.00) |
0.0493 (0.225) |
3p gain | 11 (2%) | 501 |
0.0362 (0.183) |
0.0849 (0.307) |
0.551 (0.856) |
1 (1.00) |
0.813 (0.985) |
0.0287 (0.16) |
1 (1.00) |
1 (1.00) |
3q gain | 8 (2%) | 504 |
0.00194 (0.0231) |
0.0332 (0.179) |
0.476 (0.816) |
0.413 (0.747) |
0.304 (0.626) |
0.0914 (0.32) |
1 (1.00) |
1 (1.00) |
5p gain | 11 (2%) | 501 |
0.0283 (0.16) |
0.0321 (0.176) |
1 (1.00) |
0.542 (0.851) |
0.8 (0.982) |
0.245 (0.561) |
0.0809 (0.297) |
1 (1.00) |
5q gain | 8 (2%) | 504 |
0.0505 (0.225) |
0.0748 (0.286) |
1 (1.00) |
1 (1.00) |
0.542 (0.851) |
0.9 (1.00) |
0.0439 (0.21) |
1 (1.00) |
9p gain | 17 (3%) | 495 |
0.285 (0.6) |
0.104 (0.344) |
0.0442 (0.21) |
0.0351 (0.179) |
0.583 (0.873) |
0.236 (0.55) |
0.655 (0.905) |
1 (1.00) |
11p gain | 31 (6%) | 481 |
0.223 (0.536) |
0.0384 (0.193) |
0.266 (0.575) |
0.244 (0.561) |
0.436 (0.768) |
0.00674 (0.0546) |
1 (1.00) |
0.442 (0.774) |
19q gain | 25 (5%) | 487 |
1.32e-07 (6.12e-06) |
7.02e-06 (0.000217) |
0.416 (0.747) |
0.0683 (0.279) |
0.0686 (0.279) |
0.156 (0.437) |
0.0964 (0.325) |
0.67 (0.905) |
22q gain | 23 (4%) | 489 |
0.768 (0.974) |
0.0457 (0.214) |
0.831 (0.999) |
0.122 (0.371) |
0.194 (0.487) |
0.00411 (0.0404) |
0.732 (0.947) |
0.159 (0.442) |
3p loss | 30 (6%) | 482 |
0.0466 (0.217) |
0.883 (1.00) |
0.45 (0.785) |
0.242 (0.56) |
0.00198 (0.0231) |
0.914 (1.00) |
0.313 (0.633) |
0.431 (0.766) |
5p loss | 34 (7%) | 478 |
0.67 (0.905) |
0.342 (0.662) |
0.724 (0.94) |
0.00728 (0.0583) |
0.366 (0.701) |
0.0139 (0.0929) |
0.675 (0.905) |
0.154 (0.436) |
5q loss | 33 (6%) | 479 |
0.165 (0.445) |
0.255 (0.571) |
0.47 (0.812) |
0.00311 (0.0335) |
0.921 (1.00) |
0.0247 (0.146) |
0.669 (0.905) |
0.713 (0.93) |
11q loss | 21 (4%) | 491 |
9.85e-05 (0.00199) |
0.149 (0.427) |
1 (1.00) |
0.081 (0.297) |
0.0841 (0.306) |
0.0131 (0.0906) |
1 (1.00) |
1 (1.00) |
16p loss | 14 (3%) | 498 |
0.0509 (0.225) |
0.000244 (0.00427) |
1 (1.00) |
0.266 (0.575) |
0.151 (0.429) |
0.744 (0.96) |
0.582 (0.873) |
0.239 (0.556) |
16q loss | 22 (4%) | 490 |
0.0737 (0.285) |
0.000217 (0.00392) |
0.664 (0.905) |
0.021 (0.132) |
0.075 (0.286) |
0.512 (0.832) |
0.493 (0.821) |
0.652 (0.905) |
18q loss | 62 (12%) | 450 |
0.669 (0.905) |
0.0236 (0.141) |
0.499 (0.824) |
0.885 (1.00) |
0.878 (1.00) |
0.0326 (0.178) |
0.105 (0.345) |
0.784 (0.975) |
19p loss | 25 (5%) | 487 |
0.824 (0.993) |
0.804 (0.983) |
1 (1.00) |
0.513 (0.832) |
0.0779 (0.292) |
0.933 (1.00) |
0.0187 (0.12) |
0.0514 (0.225) |
21q loss | 36 (7%) | 476 |
0.906 (1.00) |
0.617 (0.897) |
0.493 (0.821) |
0.26 (0.574) |
0.00633 (0.0526) |
0.00359 (0.0369) |
0.57 (0.865) |
1 (1.00) |
1q gain | 23 (4%) | 489 |
0.364 (0.699) |
5.1e-05 (0.00118) |
0.522 (0.836) |
0.655 (0.905) |
0.115 (0.362) |
0.0807 (0.297) |
0.278 (0.594) |
0.385 (0.721) |
4p gain | 13 (3%) | 499 |
0.722 (0.939) |
0.646 (0.905) |
1 (1.00) |
0.387 (0.721) |
0.797 (0.982) |
0.0235 (0.141) |
0.188 (0.477) |
1 (1.00) |
8q gain | 56 (11%) | 456 |
0.545 (0.852) |
0.166 (0.445) |
0.67 (0.905) |
0.0256 (0.147) |
0.278 (0.594) |
0.128 (0.381) |
0.641 (0.905) |
0.143 (0.418) |
10q gain | 12 (2%) | 500 |
0.926 (1.00) |
0.251 (0.567) |
1 (1.00) |
0.385 (0.721) |
0.757 (0.969) |
0.00351 (0.0367) |
0.107 (0.347) |
0.164 (0.444) |
12p gain | 33 (6%) | 479 |
0.327 (0.642) |
0.438 (0.769) |
0.208 (0.509) |
0.0227 (0.139) |
0.854 (1.00) |
0.33 (0.645) |
0.434 (0.767) |
1 (1.00) |
12q gain | 16 (3%) | 496 |
0.00579 (0.0514) |
0.307 (0.627) |
0.317 (0.636) |
0.425 (0.757) |
0.0739 (0.285) |
0.859 (1.00) |
0.172 (0.453) |
0.615 (0.896) |
13q gain | 6 (1%) | 506 |
0.411 (0.747) |
0.94 (1.00) |
1 (1.00) |
0.0339 (0.179) |
0.0688 (0.279) |
1 (1.00) |
1 (1.00) |
1 (1.00) |
16q gain | 19 (4%) | 493 |
0.416 (0.747) |
0.606 (0.894) |
0.49 (0.821) |
0.461 (0.798) |
0.629 (0.902) |
0.0142 (0.0942) |
0.677 (0.905) |
0.623 (0.897) |
17q gain | 23 (4%) | 489 |
0.00316 (0.0335) |
0.118 (0.367) |
0.0858 (0.309) |
0.664 (0.905) |
0.946 (1.00) |
0.276 (0.592) |
0.261 (0.574) |
0.636 (0.905) |
18p gain | 17 (3%) | 495 |
0.000687 (0.0101) |
0.993 (1.00) |
0.621 (0.897) |
0.613 (0.896) |
0.39 (0.722) |
0.383 (0.721) |
0.283 (0.599) |
0.615 (0.896) |
18q gain | 13 (3%) | 499 |
0.000516 (0.00815) |
0.781 (0.975) |
1 (1.00) |
0.0915 (0.32) |
0.514 (0.832) |
0.458 (0.796) |
0.192 (0.484) |
1 (1.00) |
21q gain | 24 (5%) | 488 |
0.178 (0.455) |
0.00597 (0.0516) |
0.401 (0.737) |
0.177 (0.454) |
0.124 (0.372) |
0.868 (1.00) |
0.408 (0.745) |
0.393 (0.726) |
xp gain | 21 (4%) | 491 |
0.818 (0.987) |
0.994 (1.00) |
0.119 (0.367) |
0.246 (0.561) |
0.5 (0.824) |
0.0349 (0.179) |
0.259 (0.574) |
1 (1.00) |
1q loss | 25 (5%) | 487 |
0.524 (0.836) |
0.0945 (0.322) |
0.837 (1.00) |
1 (1.00) |
0.596 (0.886) |
0.0045 (0.0423) |
0.211 (0.514) |
1 (1.00) |
2p loss | 21 (4%) | 491 |
0.302 (0.625) |
0.528 (0.839) |
0.656 (0.905) |
0.0138 (0.0929) |
0.0695 (0.28) |
0.229 (0.543) |
1 (1.00) |
0.385 (0.721) |
2q loss | 18 (4%) | 494 |
0.904 (1.00) |
0.48 (0.82) |
0.81 (0.984) |
0.12 (0.367) |
0.228 (0.543) |
0.0492 (0.225) |
1 (1.00) |
0.623 (0.897) |
3q loss | 28 (5%) | 484 |
0.0245 (0.146) |
0.443 (0.775) |
0.697 (0.918) |
0.3 (0.623) |
0.0982 (0.328) |
0.969 (1.00) |
0.28 (0.594) |
0.7 (0.92) |
4q loss | 92 (18%) | 420 |
0.32 (0.636) |
0.15 (0.429) |
0.203 (0.503) |
0.712 (0.93) |
0.745 (0.96) |
0.00617 (0.0526) |
0.871 (1.00) |
1 (1.00) |
8p loss | 17 (3%) | 495 |
0.045 (0.213) |
0.174 (0.453) |
0.81 (0.984) |
0.0912 (0.32) |
0.334 (0.649) |
0.387 (0.721) |
0.113 (0.358) |
0.317 (0.636) |
8q loss | 11 (2%) | 501 |
0.0438 (0.21) |
0.111 (0.356) |
0.551 (0.856) |
0.163 (0.444) |
0.514 (0.832) |
0.8 (0.982) |
0.0931 (0.322) |
0.164 (0.444) |
12q loss | 51 (10%) | 461 |
0.862 (1.00) |
0.161 (0.444) |
0.658 (0.905) |
0.163 (0.444) |
0.944 (1.00) |
0.00457 (0.0423) |
0.788 (0.975) |
0.234 (0.55) |
13q loss | 116 (23%) | 396 |
0.382 (0.721) |
0.68 (0.905) |
0.168 (0.449) |
0.000824 (0.0116) |
0.146 (0.426) |
0.568 (0.865) |
0.298 (0.622) |
0.388 (0.721) |
18p loss | 68 (13%) | 444 |
0.672 (0.905) |
0.002 (0.0231) |
0.116 (0.363) |
1 (1.00) |
0.474 (0.815) |
0.147 (0.426) |
0.1 (0.333) |
0.784 (0.975) |
20p loss | 7 (1%) | 505 |
0.9 (1.00) |
0.858 (1.00) |
0.251 (0.567) |
0.0469 (0.217) |
0.434 (0.767) |
0.494 (0.821) |
0.148 (0.426) |
0.386 (0.721) |
xq loss | 71 (14%) | 441 |
0.00453 (0.0423) |
0.174 (0.453) |
0.523 (0.836) |
0.0954 (0.324) |
0.164 (0.444) |
0.76 (0.969) |
0.653 (0.905) |
1 (1.00) |
2p gain | 14 (3%) | 498 |
0.148 (0.426) |
0.0783 (0.292) |
0.787 (0.975) |
0.387 (0.721) |
0.492 (0.821) |
0.549 (0.856) |
1 (1.00) |
0.599 (0.888) |
2q gain | 13 (3%) | 499 |
0.319 (0.636) |
0.172 (0.453) |
0.577 (0.868) |
0.141 (0.415) |
0.492 (0.821) |
0.562 (0.863) |
1 (1.00) |
0.569 (0.865) |
4q gain | 6 (1%) | 506 |
0.0617 (0.256) |
0.174 (0.453) |
0.697 (0.918) |
0.413 (0.747) |
0.113 (0.358) |
1 (1.00) |
1 (1.00) |
|
6p gain | 7 (1%) | 505 |
0.688 (0.912) |
0.123 (0.372) |
0.251 (0.567) |
0.0865 (0.31) |
0.815 (0.986) |
0.236 (0.55) |
1 (1.00) |
1 (1.00) |
8p gain | 46 (9%) | 466 |
0.614 (0.896) |
0.752 (0.967) |
0.534 (0.845) |
0.0726 (0.285) |
0.0981 (0.328) |
0.322 (0.637) |
1 (1.00) |
0.516 (0.832) |
11q gain | 58 (11%) | 454 |
0.166 (0.445) |
0.122 (0.371) |
0.263 (0.575) |
0.774 (0.975) |
0.787 (0.975) |
0.235 (0.55) |
0.901 (1.00) |
0.767 (0.974) |
14q gain | 4 (1%) | 508 |
0.11 (0.353) |
0.252 (0.567) |
1 (1.00) |
0.642 (0.905) |
0.973 (1.00) |
0.839 (1.00) |
1 (1.00) |
0.243 (0.56) |
16p gain | 17 (3%) | 495 |
0.677 (0.905) |
0.0716 (0.283) |
0.621 (0.897) |
0.306 (0.627) |
0.762 (0.971) |
0.0933 (0.322) |
0.632 (0.904) |
0.615 (0.896) |
7p loss | 3 (1%) | 509 |
0.652 (0.905) |
0.643 (0.905) |
0.588 (0.878) |
0.525 (0.836) |
0.787 (0.975) |
1 (1.00) |
1 (1.00) |
|
7q loss | 3 (1%) | 509 |
0.852 (1.00) |
0.945 (1.00) |
1 (1.00) |
0.525 (0.836) |
0.973 (1.00) |
0.788 (0.975) |
1 (1.00) |
1 (1.00) |
12p loss | 26 (5%) | 486 |
0.571 (0.865) |
0.172 (0.453) |
0.686 (0.911) |
0.299 (0.622) |
0.312 (0.633) |
0.12 (0.367) |
1 (1.00) |
0.399 (0.734) |
15q loss | 51 (10%) | 461 |
0.308 (0.628) |
0.342 (0.662) |
0.658 (0.905) |
0.203 (0.503) |
0.789 (0.975) |
0.647 (0.905) |
0.786 (0.975) |
0.759 (0.969) |
17q loss | 8 (2%) | 504 |
0.424 (0.757) |
0.158 (0.442) |
1 (1.00) |
0.68 (0.905) |
0.0717 (0.283) |
0.754 (0.967) |
1 (1.00) |
0.0944 (0.322) |
20q loss | 3 (1%) | 509 |
0.931 (1.00) |
0.966 (1.00) |
0.0877 (0.312) |
1 (1.00) |
0.326 (0.642) |
0.473 (0.814) |
1 (1.00) |
0.188 (0.477) |
xp loss | 99 (19%) | 413 |
0.284 (0.599) |
0.78 (0.975) |
0.574 (0.865) |
0.0715 (0.283) |
0.334 (0.649) |
0.675 (0.905) |
0.691 (0.914) |
0.105 (0.345) |
P value = 0.00396 (logrank test), Q value = 0.04
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
1P GAIN MUTATED | 13 | 6 | 0.2 - 51.9 (19.1) |
1P GAIN WILD-TYPE | 496 | 115 | 0.0 - 211.2 (21.0) |
P value = 0.0126 (Wilcoxon-test), Q value = 0.088
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
1P GAIN MUTATED | 13 | 52.4 (12.7) |
1P GAIN WILD-TYPE | 498 | 42.7 (13.3) |
P value = 0.0341 (Fisher's exact test), Q value = 0.18
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
1P GAIN MUTATED | 1 | 11 |
1P GAIN WILD-TYPE | 183 | 282 |
P value = 0.0083 (Fisher's exact test), Q value = 0.065
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
1P GAIN MUTATED | 10 | 0 | 3 |
1P GAIN WILD-TYPE | 184 | 129 | 186 |
P value = 5.1e-05 (Wilcoxon-test), Q value = 0.0012
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
1Q GAIN MUTATED | 23 | 54.0 (11.1) |
1Q GAIN WILD-TYPE | 488 | 42.5 (13.2) |
P value = 0.0362 (logrank test), Q value = 0.18
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
3P GAIN MUTATED | 11 | 4 | 0.2 - 49.9 (17.3) |
3P GAIN WILD-TYPE | 498 | 117 | 0.0 - 211.2 (21.2) |
P value = 0.0287 (Fisher's exact test), Q value = 0.16
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
3P GAIN MUTATED | 8 | 0 | 3 |
3P GAIN WILD-TYPE | 186 | 129 | 186 |
P value = 0.00194 (logrank test), Q value = 0.023
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
3Q GAIN MUTATED | 8 | 4 | 0.2 - 47.8 (13.1) |
3Q GAIN WILD-TYPE | 501 | 117 | 0.0 - 211.2 (21.0) |
P value = 0.0332 (Wilcoxon-test), Q value = 0.18
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
3Q GAIN MUTATED | 8 | 52.8 (11.4) |
3Q GAIN WILD-TYPE | 503 | 42.8 (13.3) |
P value = 0.0235 (Fisher's exact test), Q value = 0.14
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
4P GAIN MUTATED | 9 | 0 | 4 |
4P GAIN WILD-TYPE | 185 | 129 | 185 |
P value = 0.0283 (logrank test), Q value = 0.16
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
5P GAIN MUTATED | 11 | 6 | 2.5 - 62.2 (24.4) |
5P GAIN WILD-TYPE | 498 | 115 | 0.0 - 211.2 (20.8) |
P value = 0.0321 (Wilcoxon-test), Q value = 0.18
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
5P GAIN MUTATED | 11 | 51.5 (12.3) |
5P GAIN WILD-TYPE | 500 | 42.8 (13.3) |
P value = 0.0505 (logrank test), Q value = 0.23
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
5Q GAIN MUTATED | 8 | 4 | 2.5 - 54.8 (19.5) |
5Q GAIN WILD-TYPE | 501 | 117 | 0.0 - 211.2 (20.8) |
P value = 0.0439 (Fisher's exact test), Q value = 0.21
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 1 | 8 | 21 | 472 |
5Q GAIN MUTATED | 0 | 1 | 1 | 5 |
5Q GAIN WILD-TYPE | 1 | 7 | 20 | 467 |
P value = 6.05e-09 (logrank test), Q value = 4.4e-07
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
7P GAIN MUTATED | 121 | 49 | 0.1 - 211.2 (18.4) |
7P GAIN WILD-TYPE | 388 | 72 | 0.0 - 182.3 (23.2) |
P value = 2.93e-10 (Wilcoxon-test), Q value = 2.7e-08
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
7P GAIN MUTATED | 121 | 49.7 (12.8) |
7P GAIN WILD-TYPE | 390 | 40.9 (12.8) |
P value = 0.000824 (Fisher's exact test), Q value = 0.012
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
7P GAIN MUTATED | 28 | 84 |
7P GAIN WILD-TYPE | 156 | 209 |
P value = 0.00106 (Wilcoxon-test), Q value = 0.014
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.6 (12.6) |
7P GAIN MUTATED | 74 | 81.9 (15.3) |
7P GAIN WILD-TYPE | 232 | 88.1 (11.2) |
P value = 0.0167 (Fisher's exact test), Q value = 0.11
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 1 | 8 | 21 | 472 |
7P GAIN MUTATED | 1 | 2 | 10 | 108 |
7P GAIN WILD-TYPE | 0 | 6 | 11 | 364 |
P value = 1.69e-07 (logrank test), Q value = 7.3e-06
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
7Q GAIN MUTATED | 151 | 56 | 0.1 - 211.2 (18.5) |
7Q GAIN WILD-TYPE | 358 | 65 | 0.0 - 182.3 (23.3) |
P value = 3.28e-10 (Wilcoxon-test), Q value = 2.7e-08
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
7Q GAIN MUTATED | 151 | 48.7 (13.1) |
7Q GAIN WILD-TYPE | 360 | 40.6 (12.7) |
P value = 0.000867 (Fisher's exact test), Q value = 0.012
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
7Q GAIN MUTATED | 37 | 101 |
7Q GAIN WILD-TYPE | 147 | 192 |
P value = 0.00641 (Wilcoxon-test), Q value = 0.053
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.6 (12.6) |
7Q GAIN MUTATED | 89 | 83.1 (14.6) |
7Q GAIN WILD-TYPE | 217 | 88.1 (11.4) |
P value = 0.0391 (Fisher's exact test), Q value = 0.2
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
7Q GAIN MUTATED | 68 | 39 | 44 |
7Q GAIN WILD-TYPE | 126 | 90 | 145 |
P value = 0.00963 (Fisher's exact test), Q value = 0.072
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 1 | 8 | 21 | 472 |
7Q GAIN MUTATED | 1 | 3 | 12 | 135 |
7Q GAIN WILD-TYPE | 0 | 5 | 9 | 337 |
P value = 0.0256 (Fisher's exact test), Q value = 0.15
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
8Q GAIN MUTATED | 13 | 40 |
8Q GAIN WILD-TYPE | 171 | 253 |
P value = 0.0442 (Fisher's exact test), Q value = 0.21
nPatients | FEMALE | MALE |
---|---|---|
ALL | 228 | 284 |
9P GAIN MUTATED | 12 | 5 |
9P GAIN WILD-TYPE | 216 | 279 |
P value = 0.0351 (Fisher's exact test), Q value = 0.18
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
9P GAIN MUTATED | 2 | 14 |
9P GAIN WILD-TYPE | 182 | 279 |
P value = 0.00268 (Fisher's exact test), Q value = 0.029
nPatients | FEMALE | MALE |
---|---|---|
ALL | 228 | 284 |
9Q GAIN MUTATED | 18 | 6 |
9Q GAIN WILD-TYPE | 210 | 278 |
P value = 0.00173 (Fisher's exact test), Q value = 0.021
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
9Q GAIN MUTATED | 2 | 21 |
9Q GAIN WILD-TYPE | 182 | 272 |
P value = 0.0586 (Fisher's exact test), Q value = 0.25
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
9Q GAIN MUTATED | 14 | 6 | 4 |
9Q GAIN WILD-TYPE | 180 | 123 | 185 |
P value = 0.0215 (Wilcoxon-test), Q value = 0.13
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
10P GAIN MUTATED | 57 | 38.5 (10.9) |
10P GAIN WILD-TYPE | 454 | 43.6 (13.5) |
P value = 0.011 (Fisher's exact test), Q value = 0.08
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
10P GAIN MUTATED | 12 | 42 |
10P GAIN WILD-TYPE | 172 | 251 |
P value = 0.00017 (Fisher's exact test), Q value = 0.0032
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
10P GAIN MUTATED | 32 | 17 | 8 |
10P GAIN WILD-TYPE | 162 | 112 | 181 |
P value = 0.00351 (Fisher's exact test), Q value = 0.037
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
10Q GAIN MUTATED | 10 | 0 | 2 |
10Q GAIN WILD-TYPE | 184 | 129 | 187 |
P value = 0.0384 (Wilcoxon-test), Q value = 0.19
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
11P GAIN MUTATED | 31 | 48.4 (14.8) |
11P GAIN WILD-TYPE | 480 | 42.6 (13.2) |
P value = 0.00674 (Fisher's exact test), Q value = 0.055
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
11P GAIN MUTATED | 4 | 10 | 17 |
11P GAIN WILD-TYPE | 190 | 119 | 172 |
P value = 0.0227 (Fisher's exact test), Q value = 0.14
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
12P GAIN MUTATED | 6 | 25 |
12P GAIN WILD-TYPE | 178 | 268 |
P value = 0.00579 (logrank test), Q value = 0.051
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
12Q GAIN MUTATED | 16 | 9 | 1.2 - 84.3 (27.3) |
12Q GAIN WILD-TYPE | 493 | 112 | 0.0 - 211.2 (20.7) |
P value = 0.0339 (Fisher's exact test), Q value = 0.18
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
13Q GAIN MUTATED | 5 | 1 |
13Q GAIN WILD-TYPE | 179 | 292 |
P value = 0.0508 (logrank test), Q value = 0.23
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
15Q GAIN MUTATED | 11 | 6 | 2.4 - 117.4 (24.3) |
15Q GAIN WILD-TYPE | 498 | 115 | 0.0 - 211.2 (20.8) |
P value = 0.0259 (Wilcoxon-test), Q value = 0.15
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
15Q GAIN MUTATED | 11 | 51.8 (13.3) |
15Q GAIN WILD-TYPE | 500 | 42.8 (13.3) |
P value = 0.0138 (Wilcoxon-test), Q value = 0.093
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.6 (12.6) |
15Q GAIN MUTATED | 10 | 72.0 (19.9) |
15Q GAIN WILD-TYPE | 296 | 87.1 (12.0) |
P value = 0.0142 (Fisher's exact test), Q value = 0.094
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
16Q GAIN MUTATED | 13 | 1 | 5 |
16Q GAIN WILD-TYPE | 181 | 128 | 184 |
P value = 0.00555 (logrank test), Q value = 0.05
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
17P GAIN MUTATED | 20 | 8 | 8.1 - 62.2 (20.0) |
17P GAIN WILD-TYPE | 489 | 113 | 0.0 - 211.2 (20.8) |
P value = 0.0176 (Wilcoxon-test), Q value = 0.11
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
17P GAIN MUTATED | 20 | 49.9 (13.4) |
17P GAIN WILD-TYPE | 491 | 42.7 (13.3) |
P value = 0.0595 (Fisher's exact test), Q value = 0.25
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
17P GAIN MUTATED | 11 | 1 | 8 |
17P GAIN WILD-TYPE | 183 | 128 | 181 |
P value = 0.00316 (logrank test), Q value = 0.034
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
17Q GAIN MUTATED | 23 | 9 | 5.8 - 62.2 (19.0) |
17Q GAIN WILD-TYPE | 486 | 112 | 0.0 - 211.2 (20.9) |
P value = 0.000687 (logrank test), Q value = 0.01
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
18P GAIN MUTATED | 17 | 9 | 0.2 - 51.9 (20.8) |
18P GAIN WILD-TYPE | 492 | 112 | 0.0 - 211.2 (20.9) |
P value = 0.000516 (logrank test), Q value = 0.0081
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
18Q GAIN MUTATED | 13 | 8 | 0.2 - 51.9 (29.1) |
18Q GAIN WILD-TYPE | 496 | 113 | 0.0 - 211.2 (20.8) |
P value = 0.013 (Wilcoxon-test), Q value = 0.091
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
19P GAIN MUTATED | 99 | 46.2 (14.2) |
19P GAIN WILD-TYPE | 412 | 42.2 (13.0) |
P value = 0.0581 (Fisher's exact test), Q value = 0.25
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
19P GAIN MUTATED | 44 | 49 |
19P GAIN WILD-TYPE | 140 | 244 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00027
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
19P GAIN MUTATED | 20 | 19 | 61 |
19P GAIN WILD-TYPE | 174 | 110 | 128 |
P value = 1.32e-07 (logrank test), Q value = 6.1e-06
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
19Q GAIN MUTATED | 25 | 11 | 0.2 - 54.8 (16.8) |
19Q GAIN WILD-TYPE | 484 | 110 | 0.0 - 211.2 (21.5) |
P value = 7.02e-06 (Wilcoxon-test), Q value = 0.00022
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
19Q GAIN MUTATED | 25 | 55.2 (11.7) |
19Q GAIN WILD-TYPE | 486 | 42.4 (13.1) |
P value = 8.27e-12 (logrank test), Q value = 8.9e-10
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
20P GAIN MUTATED | 43 | 21 | 0.5 - 54.8 (16.2) |
20P GAIN WILD-TYPE | 466 | 100 | 0.0 - 211.2 (21.6) |
P value = 2.19e-08 (Wilcoxon-test), Q value = 1.4e-06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
20P GAIN MUTATED | 43 | 54.4 (12.1) |
20P GAIN WILD-TYPE | 468 | 41.9 (13.0) |
P value = 0.0401 (Fisher's exact test), Q value = 0.2
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
20P GAIN MUTATED | 9 | 30 |
20P GAIN WILD-TYPE | 175 | 263 |
P value = 0.0124 (Wilcoxon-test), Q value = 0.088
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.6 (12.6) |
20P GAIN MUTATED | 26 | 81.2 (14.0) |
20P GAIN WILD-TYPE | 280 | 87.1 (12.3) |
P value = 1.17e-12 (logrank test), Q value = 1.5e-10
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
20Q GAIN MUTATED | 43 | 21 | 0.5 - 54.8 (16.2) |
20Q GAIN WILD-TYPE | 466 | 100 | 0.0 - 211.2 (21.8) |
P value = 2.98e-08 (Wilcoxon-test), Q value = 1.8e-06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
20Q GAIN MUTATED | 43 | 54.4 (12.3) |
20Q GAIN WILD-TYPE | 468 | 41.9 (13.0) |
P value = 0.0405 (Fisher's exact test), Q value = 0.2
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
20Q GAIN MUTATED | 9 | 31 |
20Q GAIN WILD-TYPE | 175 | 262 |
P value = 0.0124 (Wilcoxon-test), Q value = 0.088
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.6 (12.6) |
20Q GAIN MUTATED | 26 | 81.2 (14.0) |
20Q GAIN WILD-TYPE | 280 | 87.1 (12.3) |
P value = 0.00597 (Wilcoxon-test), Q value = 0.052
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
21Q GAIN MUTATED | 24 | 52.0 (17.0) |
21Q GAIN WILD-TYPE | 487 | 42.5 (13.0) |
P value = 0.0457 (Wilcoxon-test), Q value = 0.21
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
22Q GAIN MUTATED | 23 | 48.0 (11.3) |
22Q GAIN WILD-TYPE | 488 | 42.8 (13.4) |
P value = 0.00411 (Fisher's exact test), Q value = 0.04
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
22Q GAIN MUTATED | 3 | 4 | 16 |
22Q GAIN WILD-TYPE | 191 | 125 | 173 |
P value = 0.0349 (Fisher's exact test), Q value = 0.18
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
XP GAIN MUTATED | 13 | 5 | 3 |
XP GAIN WILD-TYPE | 181 | 124 | 186 |
P value = 0.0496 (Wilcoxon-test), Q value = 0.22
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
XQ GAIN MUTATED | 39 | 39.4 (12.3) |
XQ GAIN WILD-TYPE | 472 | 43.3 (13.4) |
P value = 0.0043 (Fisher's exact test), Q value = 0.042
nPatients | FEMALE | MALE |
---|---|---|
ALL | 228 | 284 |
XQ GAIN MUTATED | 26 | 13 |
XQ GAIN WILD-TYPE | 202 | 271 |
P value = 0.00743 (Fisher's exact test), Q value = 0.059
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
XQ GAIN MUTATED | 18 | 15 | 6 |
XQ GAIN WILD-TYPE | 176 | 114 | 183 |
P value = 0.0194 (Fisher's exact test), Q value = 0.12
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 32 | 446 |
XQ GAIN MUTATED | 6 | 28 |
XQ GAIN WILD-TYPE | 26 | 418 |
P value = 9.05e-05 (logrank test), Q value = 0.0019
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
1P LOSS MUTATED | 182 | 26 | 0.1 - 182.3 (22.2) |
1P LOSS WILD-TYPE | 327 | 95 | 0.0 - 211.2 (20.2) |
P value = 0.00101 (Wilcoxon-test), Q value = 0.013
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
1P LOSS MUTATED | 183 | 45.4 (12.8) |
1P LOSS WILD-TYPE | 328 | 41.6 (13.5) |
P value = 5.62e-08 (Fisher's exact test), Q value = 3e-06
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
1P LOSS MUTATED | 94 | 77 |
1P LOSS WILD-TYPE | 90 | 216 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00027
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
1P LOSS MUTATED | 10 | 39 | 135 |
1P LOSS WILD-TYPE | 184 | 90 | 54 |
P value = 0.0045 (Fisher's exact test), Q value = 0.042
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
1Q LOSS MUTATED | 4 | 4 | 17 |
1Q LOSS WILD-TYPE | 190 | 125 | 172 |
P value = 0.0138 (Fisher's exact test), Q value = 0.093
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
2P LOSS MUTATED | 2 | 17 |
2P LOSS WILD-TYPE | 182 | 276 |
P value = 0.0492 (Fisher's exact test), Q value = 0.22
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
2Q LOSS MUTATED | 12 | 3 | 3 |
2Q LOSS WILD-TYPE | 182 | 126 | 186 |
P value = 0.0466 (logrank test), Q value = 0.22
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
3P LOSS MUTATED | 29 | 11 | 0.1 - 84.3 (24.3) |
3P LOSS WILD-TYPE | 480 | 110 | 0.0 - 211.2 (20.7) |
P value = 0.00198 (Wilcoxon-test), Q value = 0.023
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.6 (12.6) |
3P LOSS MUTATED | 21 | 78.6 (13.9) |
3P LOSS WILD-TYPE | 285 | 87.2 (12.3) |
P value = 0.0245 (logrank test), Q value = 0.15
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
3Q LOSS MUTATED | 28 | 13 | 0.0 - 117.4 (24.2) |
3Q LOSS WILD-TYPE | 481 | 108 | 0.1 - 211.2 (20.7) |
P value = 0.00404 (Wilcoxon-test), Q value = 0.04
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
4P LOSS MUTATED | 71 | 47.0 (12.5) |
4P LOSS WILD-TYPE | 440 | 42.3 (13.4) |
P value = 0.0542 (Fisher's exact test), Q value = 0.24
nPatients | FEMALE | MALE |
---|---|---|
ALL | 228 | 284 |
4P LOSS MUTATED | 24 | 47 |
4P LOSS WILD-TYPE | 204 | 237 |
P value = 3e-04 (Fisher's exact test), Q value = 0.0051
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
4P LOSS MUTATED | 13 | 19 | 39 |
4P LOSS WILD-TYPE | 181 | 110 | 150 |
P value = 0.00617 (Fisher's exact test), Q value = 0.053
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
4Q LOSS MUTATED | 23 | 23 | 46 |
4Q LOSS WILD-TYPE | 171 | 106 | 143 |
P value = 0.00728 (Fisher's exact test), Q value = 0.058
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
5P LOSS MUTATED | 5 | 26 |
5P LOSS WILD-TYPE | 179 | 267 |
P value = 0.0139 (Fisher's exact test), Q value = 0.093
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
5P LOSS MUTATED | 18 | 11 | 5 |
5P LOSS WILD-TYPE | 176 | 118 | 184 |
P value = 0.00311 (Fisher's exact test), Q value = 0.034
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
5Q LOSS MUTATED | 4 | 26 |
5Q LOSS WILD-TYPE | 180 | 267 |
P value = 0.0247 (Fisher's exact test), Q value = 0.15
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
5Q LOSS MUTATED | 20 | 6 | 7 |
5Q LOSS WILD-TYPE | 174 | 123 | 182 |
P value = 8.3e-05 (logrank test), Q value = 0.0019
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
6P LOSS MUTATED | 30 | 13 | 0.2 - 65.4 (19.3) |
6P LOSS WILD-TYPE | 479 | 108 | 0.0 - 211.2 (21.0) |
P value = 0.0548 (Wilcoxon-test), Q value = 0.24
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
6P LOSS MUTATED | 30 | 47.7 (14.7) |
6P LOSS WILD-TYPE | 481 | 42.7 (13.2) |
P value = 0.0578 (Fisher's exact test), Q value = 0.25
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
6P LOSS MUTATED | 5 | 20 |
6P LOSS WILD-TYPE | 179 | 273 |
P value = 1.96e-05 (logrank test), Q value = 0.00049
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
6Q LOSS MUTATED | 61 | 20 | 0.1 - 65.4 (17.9) |
6Q LOSS WILD-TYPE | 448 | 101 | 0.0 - 211.2 (21.8) |
P value = 0.0291 (Wilcoxon-test), Q value = 0.16
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
6Q LOSS MUTATED | 62 | 46.4 (13.7) |
6Q LOSS WILD-TYPE | 449 | 42.5 (13.2) |
P value = 0.0256 (Fisher's exact test), Q value = 0.15
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
6Q LOSS MUTATED | 13 | 40 |
6Q LOSS WILD-TYPE | 171 | 253 |
P value = 0.000617 (Wilcoxon-test), Q value = 0.0095
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.6 (12.6) |
6Q LOSS MUTATED | 40 | 80.8 (12.9) |
6Q LOSS WILD-TYPE | 266 | 87.5 (12.3) |
P value = 0.00136 (Fisher's exact test), Q value = 0.017
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
6Q LOSS MUTATED | 37 | 10 | 15 |
6Q LOSS WILD-TYPE | 157 | 119 | 174 |
P value = 0.0512 (Fisher's exact test), Q value = 0.23
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 1 | 8 | 21 | 472 |
6Q LOSS MUTATED | 1 | 1 | 5 | 55 |
6Q LOSS WILD-TYPE | 0 | 7 | 16 | 417 |
P value = 0.045 (logrank test), Q value = 0.21
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
8P LOSS MUTATED | 16 | 6 | 0.2 - 51.9 (19.9) |
8P LOSS WILD-TYPE | 493 | 115 | 0.0 - 211.2 (21.0) |
P value = 0.0438 (logrank test), Q value = 0.21
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
8Q LOSS MUTATED | 11 | 4 | 0.2 - 51.9 (19.1) |
8Q LOSS WILD-TYPE | 498 | 117 | 0.0 - 211.2 (21.2) |
P value = 3.1e-06 (logrank test), Q value = 0.00011
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
9P LOSS MUTATED | 116 | 44 | 0.1 - 169.8 (20.4) |
9P LOSS WILD-TYPE | 393 | 77 | 0.0 - 211.2 (21.3) |
P value = 0.00204 (Wilcoxon-test), Q value = 0.023
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
9P LOSS MUTATED | 116 | 46.2 (13.2) |
9P LOSS WILD-TYPE | 395 | 42.0 (13.3) |
P value = 0.000963 (Fisher's exact test), Q value = 0.013
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
9P LOSS MUTATED | 26 | 79 |
9P LOSS WILD-TYPE | 158 | 214 |
P value = 0.0022 (Wilcoxon-test), Q value = 0.025
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.6 (12.6) |
9P LOSS MUTATED | 75 | 83.1 (13.0) |
9P LOSS WILD-TYPE | 231 | 87.8 (12.2) |
P value = 0.0582 (Fisher's exact test), Q value = 0.25
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
9P LOSS MUTATED | 55 | 23 | 39 |
9P LOSS WILD-TYPE | 139 | 106 | 150 |
P value = 0.00858 (logrank test), Q value = 0.065
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
9Q LOSS MUTATED | 50 | 20 | 0.1 - 169.8 (21.6) |
9Q LOSS WILD-TYPE | 459 | 101 | 0.0 - 211.2 (20.8) |
P value = 0.00595 (Wilcoxon-test), Q value = 0.052
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
9Q LOSS MUTATED | 50 | 48.1 (14.7) |
9Q LOSS WILD-TYPE | 461 | 42.4 (13.1) |
P value = 0.011 (Fisher's exact test), Q value = 0.08
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
9Q LOSS MUTATED | 8 | 33 |
9Q LOSS WILD-TYPE | 176 | 260 |
P value = 0.000384 (Wilcoxon-test), Q value = 0.0064
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.6 (12.6) |
9Q LOSS MUTATED | 32 | 80.0 (12.2) |
9Q LOSS WILD-TYPE | 274 | 87.4 (12.4) |
P value = 0 (logrank test), Q value = 0
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
10P LOSS MUTATED | 83 | 48 | 0.1 - 134.3 (16.2) |
10P LOSS WILD-TYPE | 426 | 73 | 0.0 - 211.2 (23.5) |
P value = 5.96e-20 (Wilcoxon-test), Q value = 1.3e-17
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
10P LOSS MUTATED | 83 | 55.6 (11.0) |
10P LOSS WILD-TYPE | 428 | 40.5 (12.4) |
P value = 0.000138 (Fisher's exact test), Q value = 0.0027
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
10P LOSS MUTATED | 14 | 60 |
10P LOSS WILD-TYPE | 170 | 233 |
P value = 0.000218 (Wilcoxon-test), Q value = 0.0039
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.6 (12.6) |
10P LOSS MUTATED | 52 | 80.4 (14.9) |
10P LOSS WILD-TYPE | 254 | 87.9 (11.7) |
P value = 9e-05 (Fisher's exact test), Q value = 0.0019
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
10P LOSS MUTATED | 49 | 16 | 18 |
10P LOSS WILD-TYPE | 145 | 113 | 171 |
P value = 0.00884 (Fisher's exact test), Q value = 0.067
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 1 | 8 | 21 | 472 |
10P LOSS MUTATED | 1 | 1 | 8 | 72 |
10P LOSS WILD-TYPE | 0 | 7 | 13 | 400 |
P value = 0 (logrank test), Q value = 0
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
10Q LOSS MUTATED | 96 | 54 | 0.1 - 172.8 (16.5) |
10Q LOSS WILD-TYPE | 413 | 67 | 0.0 - 211.2 (23.5) |
P value = 2.03e-17 (Wilcoxon-test), Q value = 3.3e-15
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
10Q LOSS MUTATED | 96 | 53.6 (12.3) |
10Q LOSS WILD-TYPE | 415 | 40.5 (12.3) |
P value = 4.74e-06 (Fisher's exact test), Q value = 0.00015
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
10Q LOSS MUTATED | 15 | 71 |
10Q LOSS WILD-TYPE | 169 | 222 |
P value = 0.000462 (Wilcoxon-test), Q value = 0.0075
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.6 (12.6) |
10Q LOSS MUTATED | 59 | 81.0 (14.9) |
10Q LOSS WILD-TYPE | 247 | 88.0 (11.6) |
P value = 4e-05 (Fisher's exact test), Q value = 0.00096
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
10Q LOSS MUTATED | 56 | 19 | 21 |
10Q LOSS WILD-TYPE | 138 | 110 | 168 |
P value = 0.0252 (Fisher's exact test), Q value = 0.15
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 1 | 8 | 21 | 472 |
10Q LOSS MUTATED | 1 | 1 | 8 | 85 |
10Q LOSS WILD-TYPE | 0 | 7 | 13 | 387 |
P value = 0.0222 (logrank test), Q value = 0.14
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
11P LOSS MUTATED | 63 | 24 | 0.2 - 156.2 (20.2) |
11P LOSS WILD-TYPE | 446 | 97 | 0.0 - 211.2 (21.0) |
P value = 0.00625 (Fisher's exact test), Q value = 0.053
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
11P LOSS MUTATED | 13 | 46 |
11P LOSS WILD-TYPE | 171 | 247 |
P value = 0.00065 (Fisher's exact test), Q value = 0.0098
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
11P LOSS MUTATED | 37 | 14 | 12 |
11P LOSS WILD-TYPE | 157 | 115 | 177 |
P value = 9.85e-05 (logrank test), Q value = 0.002
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
11Q LOSS MUTATED | 21 | 9 | 0.2 - 54.8 (18.7) |
11Q LOSS WILD-TYPE | 488 | 112 | 0.0 - 211.2 (21.4) |
P value = 0.0131 (Fisher's exact test), Q value = 0.091
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
11Q LOSS MUTATED | 13 | 6 | 2 |
11Q LOSS WILD-TYPE | 181 | 123 | 187 |
P value = 0.00457 (Fisher's exact test), Q value = 0.042
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
12Q LOSS MUTATED | 28 | 14 | 9 |
12Q LOSS WILD-TYPE | 166 | 115 | 180 |
P value = 0.000824 (Fisher's exact test), Q value = 0.012
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
13Q LOSS MUTATED | 28 | 84 |
13Q LOSS WILD-TYPE | 156 | 209 |
P value = 2.75e-06 (logrank test), Q value = 1e-04
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
14Q LOSS MUTATED | 79 | 33 | 0.1 - 130.8 (21.3) |
14Q LOSS WILD-TYPE | 430 | 88 | 0.0 - 211.2 (20.8) |
P value = 1.66e-05 (Wilcoxon-test), Q value = 0.00043
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
14Q LOSS MUTATED | 80 | 49.0 (13.0) |
14Q LOSS WILD-TYPE | 431 | 41.9 (13.1) |
P value = 0.0339 (Wilcoxon-test), Q value = 0.18
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.6 (12.6) |
14Q LOSS MUTATED | 50 | 83.4 (13.2) |
14Q LOSS WILD-TYPE | 256 | 87.3 (12.4) |
P value = 0.0509 (logrank test), Q value = 0.23
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
16P LOSS MUTATED | 14 | 7 | 2.4 - 78.3 (28.6) |
16P LOSS WILD-TYPE | 495 | 114 | 0.0 - 211.2 (20.7) |
P value = 0.000244 (Wilcoxon-test), Q value = 0.0043
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
16P LOSS MUTATED | 14 | 56.1 (10.7) |
16P LOSS WILD-TYPE | 497 | 42.6 (13.2) |
P value = 0.000217 (Wilcoxon-test), Q value = 0.0039
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
16Q LOSS MUTATED | 22 | 54.3 (13.8) |
16Q LOSS WILD-TYPE | 489 | 42.5 (13.1) |
P value = 0.021 (Fisher's exact test), Q value = 0.13
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
16Q LOSS MUTATED | 3 | 18 |
16Q LOSS WILD-TYPE | 181 | 275 |
P value = 0.0351 (logrank test), Q value = 0.18
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
17P LOSS MUTATED | 13 | 3 | 0.1 - 33.3 (15.0) |
17P LOSS WILD-TYPE | 496 | 118 | 0.0 - 211.2 (21.3) |
P value = 0.00849 (Wilcoxon-test), Q value = 0.065
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.6 (12.6) |
17P LOSS MUTATED | 6 | 75.0 (8.4) |
17P LOSS WILD-TYPE | 300 | 86.9 (12.5) |
P value = 0.0493 (Fisher's exact test), Q value = 0.22
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 32 | 446 |
17P LOSS MUTATED | 3 | 10 |
17P LOSS WILD-TYPE | 29 | 436 |
P value = 0.002 (Wilcoxon-test), Q value = 0.023
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
18P LOSS MUTATED | 68 | 48.1 (14.5) |
18P LOSS WILD-TYPE | 443 | 42.2 (13.0) |
P value = 0.0236 (Wilcoxon-test), Q value = 0.14
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
18Q LOSS MUTATED | 62 | 47.1 (14.7) |
18Q LOSS WILD-TYPE | 449 | 42.4 (13.1) |
P value = 0.0326 (Fisher's exact test), Q value = 0.18
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
18Q LOSS MUTATED | 20 | 10 | 32 |
18Q LOSS WILD-TYPE | 174 | 119 | 157 |
P value = 0.0187 (Fisher's exact test), Q value = 0.12
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 1 | 8 | 21 | 472 |
19P LOSS MUTATED | 0 | 1 | 4 | 19 |
19P LOSS WILD-TYPE | 1 | 7 | 17 | 453 |
P value = 0.0514 (Fisher's exact test), Q value = 0.23
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 32 | 446 |
19P LOSS MUTATED | 4 | 18 |
19P LOSS WILD-TYPE | 28 | 428 |
P value = 0.00139 (logrank test), Q value = 0.017
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
19Q LOSS MUTATED | 207 | 36 | 0.1 - 182.3 (22.4) |
19Q LOSS WILD-TYPE | 302 | 85 | 0.0 - 211.2 (20.1) |
P value = 0.0437 (Wilcoxon-test), Q value = 0.21
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
19Q LOSS MUTATED | 208 | 44.2 (12.5) |
19Q LOSS WILD-TYPE | 303 | 42.2 (13.8) |
P value = 4.1e-06 (Fisher's exact test), Q value = 0.00014
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
19Q LOSS MUTATED | 100 | 96 |
19Q LOSS WILD-TYPE | 84 | 197 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00027
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
19Q LOSS MUTATED | 23 | 44 | 142 |
19Q LOSS WILD-TYPE | 171 | 85 | 47 |
P value = 0.0469 (Fisher's exact test), Q value = 0.22
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
20P LOSS MUTATED | 0 | 7 |
20P LOSS WILD-TYPE | 184 | 286 |
P value = 0.00633 (Wilcoxon-test), Q value = 0.053
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.6 (12.6) |
21Q LOSS MUTATED | 27 | 80.4 (14.0) |
21Q LOSS WILD-TYPE | 279 | 87.2 (12.3) |
P value = 0.00359 (Fisher's exact test), Q value = 0.037
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
21Q LOSS MUTATED | 23 | 7 | 6 |
21Q LOSS WILD-TYPE | 171 | 122 | 183 |
P value = 8.53e-08 (logrank test), Q value = 4.3e-06
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
22Q LOSS MUTATED | 57 | 27 | 0.1 - 156.2 (19.3) |
22Q LOSS WILD-TYPE | 452 | 94 | 0.0 - 211.2 (21.4) |
P value = 2.06e-06 (Wilcoxon-test), Q value = 8.3e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
22Q LOSS MUTATED | 57 | 51.5 (13.8) |
22Q LOSS WILD-TYPE | 454 | 41.9 (12.9) |
P value = 0.035 (Fisher's exact test), Q value = 0.18
nPatients | NO | YES |
---|---|---|
ALL | 184 | 293 |
22Q LOSS MUTATED | 13 | 39 |
22Q LOSS WILD-TYPE | 171 | 254 |
P value = 0.00527 (Wilcoxon-test), Q value = 0.048
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.6 (12.6) |
22Q LOSS MUTATED | 35 | 80.6 (15.1) |
22Q LOSS WILD-TYPE | 271 | 87.4 (12.0) |
P value = 0.00453 (logrank test), Q value = 0.042
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 509 | 121 | 0.0 - 211.2 (20.8) |
XQ LOSS MUTATED | 70 | 23 | 0.1 - 134.3 (18.0) |
XQ LOSS WILD-TYPE | 439 | 98 | 0.0 - 211.2 (22.1) |
-
Copy number data file = broad_values_by_arm.txt from GISTIC pipeline
-
Processed Copy number data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/GDAC_Correlate_Genomic_Events_Preprocess/LGG-TP/19781938/transformed.cor.cli.txt
-
Clinical data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/Append_Data/LGG-TP/19775312/LGG-TP.merged_data.txt
-
Number of patients = 512
-
Number of significantly arm-level cnvs = 81
-
Number of selected clinical features = 8
-
Exclude regions that fewer than K tumors have mutations, K = 3
For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R
For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.